Harnessing Probiotics and Prebiotics for the Prophylaxis and Treatment of Bacterial Vaginosis

ABSTRACT: Bacterial vaginosis (BV) is the prevalent condition of reproductive-age women in the general population. BV increases the risk of miscarriage, low birth weight, preterm birth, pelvic inflammation, sexually transmitted diseases, etc. Generally, antibiotics like metronidazole and clindamycin were used for the treatment of this recurrent infection. The use of antibiotics only gives temporal relief and may cause serious conditions of antibiotic resistance, and they kill a wide range of beneficial vaginal microbes. Hence alternative treatment methods like the use of probiotics and prebiotics for the prevention of bacterial vaginosis and other bacterial infections will be more effective. They help to optimize, maintain, and restore the vaginal acidic environment and eubiosis of the vaginal ecosystem. The current review focuses on the role of probiotics and prebiotics and the combined effect of both for the treatment and prophylaxis of bacterial vaginosis and other bacterial infections. Also, the review emphasizes the understanding of the role of vaginal microbiome in modulating the health of women and as a promising solution for recurrent vaginal infections.

Authors

Institutions

Publication Details

Journal
Biosciences Biotechnology Research Asia
Published
2024-12-20
DOI
https://doi.org/10.13005/bbra/3304
Citations
1
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Harnessing Probiotics and Prebiotics for the Prophylaxis and Treatment of Bacterial Vaginosis

A. R. Nayana, T. R. Keerthi
1 citations
Biosciences Biotechnology Research Asia
Reproductive tract infections research
0.34
article

Harnessing Probiotics and Prebiotics for the Prophylaxis and Treatment of Bacterial Vaginosis

A. R. Nayana, T. R. Keerthi
article en
1 citations

Abstract

ABSTRACT: Bacterial vaginosis (BV) is the prevalent condition of reproductive-age women in the general population. BV increases the risk of miscarriage, low birth weight, preterm birth, pelvic inflammation, sexually transmitted diseases, etc. Generally, antibiotics like metronidazole and clindamycin were used for the treatment of this recurrent infection. The use of antibiotics only gives temporal relief and may cause serious conditions of antibiotic resistance, and they kill a wide range of beneficial vaginal microbes. Hence alternative treatment methods like the use of probiotics and prebiotics for the prevention of bacterial vaginosis and other bacterial infections will be more effective. They help to optimize, maintain, and restore the vaginal acidic environment and eubiosis of the vaginal ecosystem. The current review focuses on the role of probiotics and prebiotics and the combined effect of both for the treatment and prophylaxis of bacterial vaginosis and other bacterial infections. Also, the review emphasizes the understanding of the role of vaginal microbiome in modulating the health of women and as a promising solution for recurrent vaginal infections.

Biosciences Biotechnology Research AsiaVol. 21(4)
Mahatma Gandhi University (IN)
Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research, Mahatma Gandhi University
Openalex Percentile: Top 34%
Reproductive tract infections research
0.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.